Skip To Main Content
Szu-Ying Ho on Muck Rack

Szu-Ying Ho

As seen in: MDPI
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Szu-Ying

Contact Szu-Ying, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Current Trends in Neoantigen-Based Cancer Vaccines

|
By Che-Mai Chang, Wan-Hsuan Chou, Szu-Ying Ho, Hsin-Ni Liao
| MDPI
Abstract : Cancer immunotherapies are treatments that use drugs or cells to activate patients’ own immune systems against cancer cells. Among them, cancer vaccines have recently been rapidly developed. Based on tumor-specific antigens referred to as neoantigens, these vaccines can be in various forms such as messenger (m)RNA and synthetic peptides to activate cytotoxic T cells and act with or without dendritic cells.
Open in Who Shared Issue with article?
See all 1 articles